We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 12, 2021

Performance of Breast Cancer Polygenic Risk Scores in Female CHEK2 Germline Mutation Carriers

Journal of the National Cancer Institute

 

Additional Info

Journal of the National Cancer Institute
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers
J. Natl. Cancer Inst 2020 Dec 29;[EPub Ahead of Print], J Borde, C Ernst, B Wappenschmidt, D Niederacher, K Weber-Lassalle, G Schmidt, J Hauke, AS Quante, N Weber-Lassalle, J Horváth, E Pohl-Rescigno, N Arnold, A Rump, A Gehrig, J Hentschel, U Faust, V Dutrannoy, A Meindl, M Kuzyakova, S Wang-Gohrke, BHF Weber, C Sutter, AE Volk, O Giannakopoulou, A Lee, C Engel, MK Schmidt, AC Antoniou, RK Schmutzler, K Kuchenbaecker, E Hahnen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading